Dr. Peter Marks makes clear that a central impetus behind his resignation was Kennedy’s criminal response to the deepening ...

If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...

Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) and reminds investors of the April 14, ...

Medical experts reveal critical information about the growing link between HPV and oral cancer, prevention methods, and why ...

Gardasil, its vaccine for the human papillomavirus (HPV), may generate $11 billion in revenue by 2030, according to the company's estimates. Demand has, however, been a bit underwhelming of late ...

We recently published a list of Jim Cramer Focused On These 9 Stocks Recently. In this article, we are going to take a look ...